Login to view video
Video

Effect of an Oral Nutritional Supplement for improving brain energetics and cognition

Malnutrition
Nutrition & Disease Management
Nutrition Health & Wellness

Brain glucose uptake is about 10% below normal in Mild Cognitive Impairment (MCI) and deteriorates further in Alzheimer disease (AD). The objective of the randomized, placebo-controlled Benefic trial was to assess whether counteracting the brain glucose deficit with an Oral Nutritional Supplement containing a ketogenic medium chain triglyceride (kMCT-ONS), BrainXpert Energy complex, could improve cognitive performance over 6 months in people with MCI.

Author(s): Stephen C. Cunnane

person-default
Stephen C. Cunnane

Presented at

Virtual Congress of the European Union Geriatric Medicine Society (EuGMS)

If you liked this post you may also like

Please log in to your profile so we can show recommended content.